Clincosm LogoSign in Get a demo

bevacizumab

Showing 1 - 14 of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tislelizumab, Bevacizumab, Oxaliplatin Trial in Beijing (Tislelizumab+Bevacizumab+Oxaliplatin+Capecitabine)

Recruiting
  • Tislelizumab
  • +7 more
  • Beijing, China
    Lin Yang
Jul 21, 2023

Adebrelimab, Hepatocellular Carcinoma, Transformation Trial in Xiamen (TACE with adebrelimab and bevacizumab)

Not yet recruiting
  • Adebrelimab
  • +4 more
  • TACE with adebrelimab and bevacizumab
  • Xiamen, Fujian, China
    The First Affiliated Hospital of Xiamen University
Jul 25, 2023

NSCLC Stage II, Bevacizumab, Immunotherapy Trial in Guangzhou (Serplulimab combined with bevacizumab and first-line chemo)

Not yet recruiting
  • Non-small Cell Lung Cancer Stage II
  • +3 more
  • Serplulimab combined with bevacizumab and first-line chemotherapy
  • Guangzhou, Guangdong, China
    Likun Chen
Apr 10, 2023

Ovarian Carcinoma, Platinum-resistant Ovarian Cancer, Recurrent Ovarian Carcinoma Trial in Beijing (Albumin-bound paclitaxel and

Recruiting
  • Ovarian Carcinoma
  • +6 more
  • Albumin-bound paclitaxel and bevacizumab
  • Beijing, Beijing, China
    Lei Li
Mar 26, 2022

NSCLC, Bevacizumab, EGF-R Positive NSCLC Trial in Tianjin (Bevacizumab, Icotinib)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +3 more
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Mar 2, 2022

Neoadjuvant Treatment, Rectal Cancer, Bevacizumab Trial (Bevacizumab+mFOLFOX6)

Not yet recruiting
  • Neoadjuvant Treatment
  • +3 more
  • (no location specified)
Oct 28, 2021

Preoperative Bevacizumab on Perioperative Complications

Not yet recruiting
  • Colorectal Cancer
  • +3 more
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital Zhejiang University School of Med
Mar 5, 2021

Hepatocellular Carcinoma, Bevacizumab, Liver Tumors Trial (Hepatic arterial infusion chemo, Bevacizumab, Toripalimab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +4 more
  • Hepatic arterial infusion chemotherapy
  • +2 more
  • (no location specified)
Nov 12, 2020

Ovarian Tumors, Fallopian Tube Tumors, Endocrine Gland Tumors Trial in Nanjing (Niraparib, Bevacizumab)

Unknown status
  • Ovarian Neoplasms
  • +23 more
  • Nanjing, Jiangsu, China
    JiangSu Cancer Hospital
Nov 8, 2020

Brain Metastases, Non Small Cell Lung Cancer, Sintilimab Trial in Guangzhou (sintilimab)

Unknown status
  • Brain Metastases
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University of Cancer Center
Dec 25, 2019

Metastatic Colorectal Cancer, Glioblastoma, Bevacizumab Trial in Dijon (capillaroscopy, blood pressure measurement)

Completed
  • Metastatic Colorectal Cancer
  • +3 more
  • capillaroscopy
  • blood pressure measurement
  • Dijon, France
    Centre Georges François Leclerc
Mar 14, 2019

Non Squamous NSCLC, Brain Metastases, Bevacizumab Trial in Guangzhou (Pemetrexed/cisplatin, Bevacizumab and

Unknown status
  • Non Squamous Non-small Cell Lung Cancer
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University of Cancer Center
Oct 25, 2017

Pterygium, Bevacizumab, VEGF Trial in Pathumwan (bevacizumab eye drop 0.05%, normal saline 0.9%)

Completed
  • Pterygium
  • +3 more
  • bevacizumab eye drop 0.05%
  • normal saline 0.9%
  • Pathumwan, Bangkok, Thailand
    Faculty of medicine, Chulalongkorn university
Apr 6, 2013

Bevacizumab in HER2-negative Breast Cancer Neoadjuvant

Unknown status
  • Breast Cancer
  • +3 more
  • Xi'an, Shaanxi, China
    Xijing Hospital ， Fourth Military Medical University
Jul 25, 2012